The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Articles

The prestigious award, worth €20,000 (US$22,000), goes to Maurice Michel of the Science for Life Laboratory at Karolinska Institutet, Stockholm, Sweden. 

Maurice Michel of Sweden Wins 2023 Eppendorf Award for Young European Investigators

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Aenova has opened a new building for the production of highly potent APIs in Germany.

Aenova Opens New Building for Highly Potent Drugs

Feliza Mirasol is the science editor for 

The new headquarters located in Columbus, Ohio, more than triples Andelyn Biosciences’ footprint to meet growing demand for CGT services.

Andelyn Biosciences Opens New CGT Manufacturing Headquarters

PIF has established Lifera, a new manufacturing entity that will manufacture, stockpile, and supply bio/pharmaceuticals both locally and through partnerships.

Saudi Arabia’ PIF Launches Lifera, a New CDMO

India’s Enzene Biosciences is investing $50 Million into a new biopharma manufacturing plant in Hopewell, NJ.

Enzene Biosciences Invests $50 Million into New Jersey Biomanufacturing Facility

The new facility also provides a plan for scalable product production processes that can potentially be replicated by Vaxxas domestically and globally.

Vaxxas Opens Manufacturing Facility for Clinical Trials and Commercial Products

The integration of the binders into a routine lateral flow test will support the clinical and commercial development of rapid diagnostics for Alzheimer’s disease through nasal sampling.

Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer’s Disease Diagnostic Test

Mendus and NorthX Biologics will work to develop and commercialize Mendus’ lead asset, vididencel, an allogeneic dendritic cell vaccine.

Mendus and NorthXBiologics Enter Cell Therapy Manufacturing Alliance

Charles River’s off-the-shelf lentiviral vector packaging plasmids are intended for use with cell and gene therapies.


Charles River Laboratories Launches LVV Packaging Plasmids

The investment, which is taking place in Hillerød, Denmark, will aim to create more production capacity and increase the company’s ability to meet future market demands and to continue development on its future clinical late-phase product portfolio.